Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengcheng Fu

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 10, 2018
Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe ThrombocytopeniaYaqiong Tang, Xinyou Zhang, Shiyu Han, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 18, 2015
[Retrospective efficacy analysis of decitabine bridging allogeneic hematopoietic stem cell transplantation on the treatment of myelodysplastic syndrome]Huifei Zheng, Jing Wang, Jin Zhou, et al.
British Journal of Haematology|August 13, 2024
Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantationHong Wang, Xueqian Li, Jiaqian Qi, et al.
American Journal of Cancer Research|December 9, 2020
Identification of metabolic biomarkers to predict treatment outcome and disease progression in multiple myelomaRanran Zhao, Yiyu Xie, Bingyu Yang, et al.
American Journal of Hematology|January 18, 2019
Combination of bortezomib in the induction, conditioning and consolidation with autologous hematopoietic stem cell transplantation in patients with immunoglobulin light chain amyloidosisXianghua Huang, Chengcheng Fu, Lijuan Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 29, 2015
[Retrospective study of the efficacy and safety of treatment with PDD vs PAD in de novo patients with multiple myiloma]Ling Ma, Chengcheng Fu, Hui Liu, et al.
Oncotarget|October 27, 2017
Prognostic analysis of DLBCL patients and the role of upfront ASCT in high-intermediate and high-risk patientsYing Zhao, Hong Wang, Song Jin, et al.
Thrombosis Research|October 29, 2017
Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignanciesTiantian Chu, Yaqiong Tang, Hong Wang, et al.
Platelets|August 18, 2020
Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemiaTiantian Chu, Hong Wang, Xin Lv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical StudiesYifan Zhai, Qiuqiong Tang, Douglas D Fang, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 10, 2018
Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe ThrombocytopeniaYaqiong Tang, Xinyou Zhang, Shiyu Han, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 18, 2015
[Retrospective efficacy analysis of decitabine bridging allogeneic hematopoietic stem cell transplantation on the treatment of myelodysplastic syndrome]Huifei Zheng, Jing Wang, Jin Zhou, et al.
British Journal of Haematology|August 13, 2024
Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantationHong Wang, Xueqian Li, Jiaqian Qi, et al.
American Journal of Cancer Research|December 9, 2020
Identification of metabolic biomarkers to predict treatment outcome and disease progression in multiple myelomaRanran Zhao, Yiyu Xie, Bingyu Yang, et al.
American Journal of Hematology|January 18, 2019
Combination of bortezomib in the induction, conditioning and consolidation with autologous hematopoietic stem cell transplantation in patients with immunoglobulin light chain amyloidosisXianghua Huang, Chengcheng Fu, Lijuan Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 29, 2015
[Retrospective study of the efficacy and safety of treatment with PDD vs PAD in de novo patients with multiple myiloma]Ling Ma, Chengcheng Fu, Hui Liu, et al.
Oncotarget|October 27, 2017
Prognostic analysis of DLBCL patients and the role of upfront ASCT in high-intermediate and high-risk patientsYing Zhao, Hong Wang, Song Jin, et al.
Thrombosis Research|October 29, 2017
Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignanciesTiantian Chu, Yaqiong Tang, Hong Wang, et al.
Platelets|August 18, 2020
Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemiaTiantian Chu, Hong Wang, Xin Lv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical StudiesYifan Zhai, Qiuqiong Tang, Douglas D Fang, et al.
Pageof 11